Welcome to our dedicated page for MOBIX LABS SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mobix Labs, Inc. filings document the public-company disclosures of a fabless semiconductor and connectivity company serving defense, aerospace, telecommunications and other high-reliability markets. Registration statements and prospectus materials cover Class A common stock offerings, resale registration matters and financial disclosures tied to its capital needs.
Material-event reports cover securities purchase agreements, a senior secured convertible promissory note, registration rights, the completed reverse stock split of Class A and Class B common stock, and related adjustments to equity plans and outstanding securities. Proxy and annual meeting filings describe director elections, stockholder voting matters, bylaw amendments, quorum requirements and other governance provisions.
Mobix Labs, Inc. director and Chief Executive Officer Philip Sansone reported selling 9,301 shares of Class A common stock on July 16, 2026 at a weighted average price of $1.8669 per share, leaving 166,130 shares held directly. The sale was made under an irrevocable “sell to cover” election solely to satisfy tax withholding from restricted stock units vesting that day and is described as non-discretionary.
Mobix Labs, Inc. is registering the resale by existing holders of up to 3,744,161 shares of Class A Common Stock, including 2,000,000 shares tied to Series A 10% Convertible Preferred Stock and a Preferred Stock Purchase Warrant, 1,207,942 shares issued to lenders in debt settlements, 71,267 litigation settlement shares, and 464,952 RaGE Systems earnout shares. The company is not selling shares itself and will receive no proceeds from these resales, though it may receive up to $6,000,000 if the Preferred Warrant is exercised, for working capital and general corporate purposes.
As of June 8, 2026, 14,998,187 Class A and 200,491 Class B shares were outstanding, and the Offered Securities would represent about 25% of Class A shares. The prospectus warns that resale of these shares, together with other registered resale securities, could significantly depress the trading price; the stock last closed at $1.97 on July 16, 2026. Mobix highlights substantial risks, including recurring operating losses, an accumulated deficit of $166.6 million, substantial doubt about its ability to continue as a going concern, expected future capital raises (which may be dilutive), reliance on a limited number of customers, material weaknesses in internal controls, and the possibility of Nasdaq delisting if listing standards are not maintained.
The company is an emerging growth company and smaller reporting company, using reduced disclosure and internal control requirements, and recently effected a 1-for-10 reverse stock split to regain Nasdaq bid-price compliance. Recent financing and strategic actions include preferred stock and warrant financing with Kips Bay Select, LP, convertible notes with Leviston Resources, LLC (partly converted into equity and partly outstanding), share-for-debt settlements, earnout structures tied to acquisitions of EMI Solutions and RaGE Systems, and non-binding letters of intent for additional acquisitions, all of which may lead to further share issuance and dilution if completed.
A Form 144 notice for Mobix Labs reports that Philip Sansone plans to sell 25,000 shares of common stock. These shares are scheduled to be acquired through RSU vesting on 07/16/2026 and may be sold beginning 07/17/2026 through J.P. Morgan Securities LLC on NASDAQ.
The notice also lists a prior sale of common stock on 05/01/2026 involving 9,541 shares within the past three months.
Mobix Labs, Inc. is registering up to 3,744,161 shares of Class A Common Stock for resale by existing stockholders. The shares include stock issued on debt settlements, litigation settlement and RaGE Systems earnout, plus shares issuable from new Series A 10% Convertible Preferred Stock and a related warrant. Mobix will not receive proceeds from these resales but may receive up to $6,000,000 if the Preferred Warrant is exercised, for working capital and general corporate purposes.
As of June 8, 2026, 14,998,187 Class A and 200,491 Class B shares were outstanding, and the offered shares would equal about 25% of Class A. The company reports large operating losses, substantial doubt about its ability to continue as a going concern, plans for further dilutive financings and multiple acquisition initiatives, all detailed in extensive risk factors.
MOBIX LABS, INC director Bill Carpou reported an equity compensation grant and his outstanding option holdings. He received 13,660 shares of Class A Common Stock on June 30, 2026 at a price of $0.00 per share, classified as a grant or award, bringing his direct holdings to 67,282 shares after the transaction. Footnotes state these Restricted Stock Units were granted on June 30, 2026 and vested on July 1, 2026, meaning they became fully earned one day after grant.
The filing also lists two fully vested stock option positions. One option covers 13,341 underlying Class A Common shares at an exercise price of $68.40 per share, expiring on April 4, 2032. Another option covers 2,000 underlying shares at an exercise price of $41.80, expiring on August 10, 2030. No open-market buys or sells were reported; the activity reflects compensation and existing derivative holdings.
MOBIX LABS, INC director and 10% owner James J. Peterson received an equity award in the form of Class A Common Stock. He acquired 13,660 shares of Class A Common Stock on a grant or award basis at a stated price of $0.00 per share, tied to Restricted Stock Units granted on June 30, 2026 that vested on July 1, 2026.
Following this award, he directly holds 339,122 shares of Class A Common Stock. He also has derivative positions linked to Class A shares: 144,927 underlying shares through Class B Common Stock that is convertible into Class A, plus fully vested options covering 13,341 shares at an exercise price of $68.40 per share expiring on April 4, 2032, and 2,000 shares at $41.80 per share expiring on August 10, 2030.
LONG MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
MOBIX LABS, INC director Michael J. Long received an equity award in the form of restricted stock units. The Form 4 shows a grant of 13,660 shares of Class A common stock at no cash cost to him, increasing his directly held position to 138,592 shares.
The footnote explains these Restricted Stock Units were granted on June 30, 2026 and vested on July 1, 2026, indicating this was a compensation-related award rather than an open-market purchase or sale.
Goerner Frederick C reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs director Frederick C. Goerner received an equity award of 13,660 shares of Class A Common Stock on June 30, 2026, at a price of $0.0000 per share. These shares relate to Restricted Stock Units granted on June 30, 2026 that vested on July 1, 2026. Following this grant, he directly holds 185,717 shares of Class A Common Stock. He also holds Class B Common Stock convertible into 21,739 Class A shares at his option, plus fully vested options to buy 13,341 Class A shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.
Mobix Labs director Kurt Busch reported a new equity grant. He received 13,660 shares of Class A Common Stock as a grant or award at a price of $0.00 per share, increasing his direct holdings to 74,621 shares. Footnotes state these Restricted Stock Units were granted on June 30, 2026 and vested on July 1, 2026.
He also holds fully vested options to buy 13,341 shares at an exercise price of $68.40 per share expiring on April 4, 2032, and options to buy 2,000 shares at $41.80 per share expiring on August 10, 2030.